# C4 Therapeutics partnered with Roche over a cancer drug endeavor valued at over $1 billion.

*biotech · news · 2026-04-11 · Devdiscourse*

## Key points

- C4 Therapeutics and Roche formed a cancer drug partnership valued at over $1 billion.
- AG1 is considering a sale, opening opportunities for new entrants in the supplement market.
- Granules has strengthened its protocols following FDA warnings to improve regulatory compliance.
- Recent research links genetic variations to differing responses to obesity drugs.

**Companies:** Roche, C4 Therapeutics, AG1, Granules

[Read the full story on Devdiscourse](https://www.devdiscourse.com/article/health/3870603-power-moves-and-pivotal-research-in-the-health-sector-new-collaborations-challenges-and-innovations)

---

Canonical: https://newsio.io/n/22e50d3b-6787-48b6-a0d2-a2002c38b838/c4-therapeutics-partnered-with-roche-over-a-cancer-drug-endeavor-valued-at-over
Summarized by Newsio from Devdiscourse. https://newsio.io/how-it-works